Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion type Assertion NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_head.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion description "[Similarly, inhibition of PPT1 with a synthetic inhibitor (AcG-palmitoyl diaminoproprionate-VKIKK) (DAP1) (100 microM) increased the susceptibility of the cells to apoptosis induced by either C(2)-ceramide or etoposide, a common chemotherapeutic agent used in the treatment of neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_provenance.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion evidence source_evidence_literature NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_provenance.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion SIO_000772 11020216 NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_provenance.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion wasDerivedFrom befree-20140225 NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_provenance.
- NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_assertion wasGeneratedBy ECO_0000203 NP853171.RADipnHgxfLeykhAKc-Ygi5QFz2tle-PoN4Pl-QGlpP8I130_provenance.